Fisher Edward M, Richardson Aaron W, Harpest Shannon D, Hofacre Kent C, Shaffer Ronald E
National Institute for Occupational Safety and Health, National Personal Protective Technology Laboratory, Pittsburgh, PA 15236, USA.
Ann Occup Hyg. 2012 Apr;56(3):315-25. doi: 10.1093/annhyg/mer101. Epub 2011 Nov 29.
The supply of N95 filtering facepiece respirators (FFRs) may not be adequate to match demand during a pandemic outbreak. One possible strategy to maintain supplies in healthcare settings is to extend FFR use for multiple patient encounters; however, contaminated FFRs may serve as a source for the airborne transmission of virus particles. In this study, reaerosolization of virus particles from contaminated FFRs was examined using bacteriophage MS2 as a surrogate for airborne pathogenic viruses. MS2 was applied to FFRs as droplets or droplet nuclei. A simulated cough (370 l min(-1) peak flow) provided reverse airflow through the contaminated FFR. The number and size of the reaerosolized particles were measured using gelatin filters and an Andersen Cascade Impactor (ACI). Two droplet nuclei challenges produced higher percentages of reaerosolized particles (0.21 and 0.08%) than a droplet challenge (<0.0001%). Overall, the ACI-determined size distribution of the reaerosolized particles was larger than the characterized loading virus aerosol. This study demonstrates that only a small percentage of viable MS2 viruses was reaerosolized from FFRs by reverse airflow under the conditions evaluated, suggesting that the risks of exposure due to reaerosolization associated with extended use can be considered negligible for most respiratory viruses. However, risk assessments should be updated as new viruses emerge and better workplace exposure data becomes available.
在大流行爆发期间,N95过滤式面罩呼吸器(FFR)的供应可能不足以满足需求。在医疗机构中维持供应的一种可能策略是延长FFR在多次患者接触中的使用;然而,受污染的FFR可能成为病毒颗粒空气传播的来源。在本研究中,使用噬菌体MS2作为空气传播致病病毒的替代物,检测了受污染FFR中病毒颗粒的再气溶胶化情况。将MS2以液滴或液滴核的形式应用于FFR。模拟咳嗽(峰值流量370 l min⁻¹)为通过受污染FFR的反向气流提供动力。使用明胶过滤器和安德森级联撞击器(ACI)测量再气溶胶化颗粒的数量和大小。两次液滴核挑战产生的再气溶胶化颗粒百分比(0.21%和0.08%)高于液滴挑战(<0.0001%)。总体而言,ACI测定的再气溶胶化颗粒的大小分布大于特征性负载病毒气溶胶。本研究表明,在评估的条件下,通过反向气流从FFR中再气溶胶化的存活MS2病毒仅占一小部分,这表明对于大多数呼吸道病毒而言,与延长使用相关的再气溶胶化暴露风险可被视为可忽略不计。然而,随着新病毒的出现和更好的工作场所暴露数据的获得,风险评估应予以更新。